Key Developments in Cannabis: Texas Expansion, Native American Brand Launch, and CBD Research

The Texas Department of Public Safety has initiated Phase I of the expansion of the Texas Compassionate Use Program (TCUP), marking a significant step forward in the state's medical cannabis landscape. Nine companies, including Verano Texas, LLC and Trulieve TX, Inc, have been selected for further evaluation. This phase involves a rigorous due diligence process that assesses each company's financial stability, litigation history, and compliance with regulatory standards. The expansion aims to increase access to medical cannabis for patients across Texas

In a groundbreaking move for cultural representation in the cannabis industry, the Holistic Health Group, operating as Suncrafted, has partnered with Tribal Fire to launch the first Native American-owned cannabis brand on the East Coast. This collaboration will see the introduction of products such as vape cartridges and pre-rolls, offering consumers the opportunity to support the Wampanoag Tribe. The partnership not only enhances market diversity but also provides economic benefits to the tribe's community in Massachusetts

Kim Stuck of Allay Consulting highlights the necessity for hemp manufacturers to pivot and adapt in the ever-evolving cannabis industry. Her advice includes securing cGMP certification and expanding product lines to stay competitive. Stuck emphasizes the importance of compliance and facility upgrades as essential strategies for businesses to thrive amidst regulatory changes. This approach is crucial for operators aiming to future-proof their operations

A recent study published in the Journal of Cannabis Research explored the effects of low-dose CBD oil on stress among university students. The randomized controlled trial involved 166 students receiving either CBD oil or a placebo over 30 days. The findings suggest that while CBD oil may have benefits, the placebo effect played a significant role in the perceived reduction of stress. This highlights the complexities involved in assessing CBD's effectiveness in psychological health

Research published in Liver International indicates that cannabidiol (CBD) could offer protective benefits against alcohol-induced liver disease (ALD). The study explored the potential of modulating the hepatic endocannabinoid system to reduce liver damage in individuals with alcohol use disorder. Although promising, these findings underscore the need for further clinical research to establish CBD's role in treating ALD, a condition lacking effective treatment options